Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness

Archives of Pediatrics and Adolescent Medicine

Volumn 155, Issue 4, 2001, Pages 496-500

  Beiter Jr , James L ^a,b   Simon, Harold K ^a   Chambliss, C Robert ^a   Adamkiewicz, Thomas ^a   Sullivan, Kevin ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC TROMETAMOL;

ADOLESCENT; ADULT; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EMERGENCY TREATMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SICKLE CELL ANEMIA;

EID: 0035066085     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.155.4.496     Document Type: Article

References (15)

1. The management of pain in sickle cell disease
2. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis
3. Intravenous narcotic therapy for children with severe sickle cell pain crisis
4. Survey of pain management therapy provided for children with sickle cell disease
5. Intravenous ketorolac as adjuvant to pediatric patient-controlled analgesia with morphine
6. The morphine sparing effect of ketorolac tromethamine
7. Safety of intravenous ketorolac in children and cost savings with a unit dosing system
8. Recovery and complications after tonsillectomy in children: A comparison of ketorolac and morphine
9. Comparison of intravenous ketorolac with morphine for postoperative pain in children
10. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis
11. Narcotic-sparing effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis [abstract]
12. The assessment of pain in children
13. Review of pain measurement tools
14. Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis
15. Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: Lack of a narcotic-sparing effect